Skip to Main Content

Author Details

Li Liu
Nanfang Hospital, Southern Medical University
2003
94
30
PMIDPaper TitleJournal TitlePublished Year
36257868Radiomics signature based on CECT for non-invasive prediction of response to anti-PD-1 therapy in patients with hepatocellular carcinoma.Clin Radiol2023
34729850Gigantol inhibits proliferation and enhanced oxidative stress-mediated apoptosis through modulating of Wnt/β-catenin signaling pathway in HeLa cells.J Biochem Mol Toxicol2022
35345821Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDIS.Clin Epidemiol2022
36215283Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer.PLoS One2022
36312959Gut microbiota distinct between colorectal cancers with deficient and proficient mismatch repair: A study of 230 CRC patients.Front Microbiol2022
33653241A New Prognostic Strategy Based on four DNA Repair-Associated lncRNAs for Hepatocellular Carcinoma.Comb Chem High Throughput Screen2022
33110233Small extracellular vesicles containing miR-30a-3p attenuate the migration and invasion of hepatocellular carcinoma by targeting SNAP23 gene.Oncogene2021
33537279Correlation Between Local Air Temperature and the COVID-19 Pandemic in Hubei, China.Front Public Health2021
33816230HILPDA Is a Prognostic Biomarker and Correlates With Macrophage Infiltration in Pan-Cancer.Front Oncol2021
33643387Identification of Prognostic Stromal-Immune Score-Based Genes in Hepatocellular Carcinoma Microenvironment.Front Genet2021
33835133Identification of a thirteen-gene signature predicting overall survival for hepatocellular carcinoma.Biosci Rep2021
33632318A new model for COVID-19 control and its implementation in the city of Honghu, China: a case report.Antimicrob Resist Infect Control2021
33688639Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS.Res Sq2021
34670386Lung metastasis and lymph node metastasis are risk factors for hyperprogressive disease in primary liver cancer patients treated with immune checkpoint inhibitors.Ann Palliat Med2021
34564278Life Table and Preference Choice of <i>Frankliniella occidentalis</i> (Thysanoptera: Thripidae) for Kidney Bean Plants Treated by Exogenous Calcium.Insects2021
34006847Dynamics of neutralizing antibody responses to SARS-CoV-2 in patients with COVID-19: an observational study.Signal Transduct Target Ther2021
34305920A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint.Front Immunol2021
31332558Residual convolutional neural network for predicting response of transarterial chemoembolization in hepatocellular carcinoma from CT imaging.Eur Radiol2020
33087136UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation.J Exp Clin Cancer Res2020
33304910Clinical Characteristics of Patients With Progressive and Non-progressive Coronavirus Disease 2019: Evidence From 365 Hospitalised Patients in Honghu and Nanchang, China.Front Med (Lausanne)2020
33046996Reciprocal regulation of HIF-1α and Uroplakin 1A promotes glycolysis and proliferation in Hepatocellular Carcinoma.J Cancer2020
33121524Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.J Exp Clin Cancer Res2020
32973971Expression of Glioma-associated oncogene homolog 1 as biomarker with sonidegib in advanced basal cell carcinoma.Oncotarget2020
32850746Development and Validation of a Deep Learning-Based Model Using Computed Tomography Imaging for Predicting Disease Severity of Coronavirus Disease 2019.Front Bioeng Biotechnol2020
32929358HRG switches TNFR1-mediated cell survival to apoptosis in Hepatocellular Carcinoma.Theranostics2020
32645614Development and validation of the HNC-LL score for predicting the severity of coronavirus disease 2019.EBioMedicine2020
32328193Self-enforcing HMGB1/NF-κB/HIF-1α Feedback Loop Promotes Cisplatin Resistance in Hepatocellular Carcinoma Cells.J Cancer2020
32490826Radiomics-based nomogram using CT imaging for noninvasive preoperative prediction of early recurrence in patients with hepatocellular carcinoma.Diagn Interv Radiol2020
32376587[Conducting clinical studies during the epidemics of communicable diseases: perspectives of methodology and health economics].Nan Fang Yi Ke Da Xue Xue Bao2020
32287040Cloud-Based System for Effective Surveillance and Control of COVID-19: Useful Experiences From Hubei, China.J Med Internet Res2020
32509068Nicotinamide nucleotide transhydrogenase acts as a new prognosis biomarker in hepatocellular carcinoma.Int J Clin Exp Pathol2020
30631060Mir20a/106a-WTX axis regulates RhoGDIa/CDC42 signaling and colon cancer progression.Nat Commun2019
34805871The potential combinational immunotherapiesfor treatment of hepatocellular carcinoma.J Interv Med2019
31786861Efficacy of apatinib in advanced hepatocellular carcinoma with lung metastasis: a retrospective, multicenter study.J BUON2019
31933938Nuclear division cycle 80 complex is associated with malignancy and predicts poor survival of hepatocellular carcinoma.Int J Clin Exp Pathol2019
31412907Correction to: Molecular pattern of lncRNAs in hepatocellular carcinoma.J Exp Clin Cancer Res2019
31495785Chromobox homolog 8 (CBX8) Interacts with Y-Box binding protein 1 (YBX1) to promote cellular proliferation in hepatocellular carcinoma cells.Aging (Albany NY)2019
31319849Nek2 augments sorafenib resistance by regulating the ubiquitination and localization of β-catenin in hepatocellular carcinoma.J Exp Clin Cancer Res2019
31097003Molecular pattern of lncRNAs in hepatocellular carcinoma.J Exp Clin Cancer Res2019
30981500PFKFB3/HIF-1α feedback loop modulates sorafenib resistance in hepatocellular carcinoma cells.Biochem Biophys Res Commun2019
29335523miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1.Oncogene2018
31949867Knockdown of <i>UACA</i> inhibitsproliferation and invasion and promotes senescence of hepatocellular carcinoma cells.Int J Clin Exp Pathol2018
30083257Identification and Functional Characterization of Long Non-coding RNA <i>MIR22HG</i> as a Tumor Suppressor for Hepatocellular Carcinoma.Theranostics2018
30588257A Randomized Controlled Study of rhTPO and rhIL-11 for the Prophylactic Treatment of Chemotherapy-Induced Thrombocytopenia in Non-Small Cell Lung Cancer.J Cancer2018
29360449miR-142-3p inhibits aerobic glycolysis and cell proliferation in hepatocellular carcinoma via targeting LDHA.Biochem Biophys Res Commun2018
29721048Multiple Antigen Stimulating Cellular Therapy (MASCT) For Hepatocellular Carcinoma After Curative Treatment: A Retrospective Study.J Cancer2018
29770763A radiomics nomogram for preoperative prediction of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma.Diagn Interv Radiol2018
29556287Increased mediator complex subunit 15 expression is associated with poor prognosis in hepatocellular carcinoma.Oncol Lett2018
27530352The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma.Oncogene2017
28330473Dynamic and specific immune responses against multiple tumor antigens were elicited in patients with hepatocellular carcinoma after cell-based immunotherapy.J Transl Med2017
  • 1 - 50 of 94

Recommended Authors

The Second Affiliated Hospital of Zhejiang University
Career Start Year 2016
Number of shared co-authors 0
Children's Hospital of Philadelphia
Career Start Year 2015
Number of shared co-authors 0
Affiliated Haixia Hospital of Huaqiao University (The Hospital)
Career Start Year 2014
Number of shared co-authors 0
Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University)
Career Start Year 2013
Number of shared co-authors 0
Guizhou Medical University
Career Start Year 2013
Number of shared co-authors 0
Shanghai East Hospital, Tongji University School of Medicine
Career Start Year 2013
Number of shared co-authors 0
UPMC Hillman Cancer Center
Career Start Year 2012
Number of shared co-authors 0
School of Pharmacy, Wannan Medical College
Career Start Year 2012
Number of shared co-authors 0
The First Affiliated Hospital, Sun Yat-sen University
Career Start Year 2012
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 0
Guangdong General Hospital, Guangdong Academy of Medical Sciences
Career Start Year 2007
Number of shared co-authors 0
The Second Affiliated Hospital of Xi'an Jiaotong University
Career Start Year 2007
Number of shared co-authors 0
Tangdu Hospital, Fourth Military Medical University
Career Start Year 2006
Number of shared co-authors 0
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 0
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2004
Number of shared co-authors 0
Shandong University of Traditional Chinese Medicine
Career Start Year 2003
Number of shared co-authors 0
College of Life Science, CHA University
Career Start Year 2003
Number of shared co-authors 0
Peking University Cancer Hospital & Institute
Career Start Year 2002
Number of shared co-authors 0
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 0
Children's Hospital, Zhejiang University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
Basic Medical College, Qingdao University
Career Start Year 1998
Number of shared co-authors 0
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Career Start Year 1997
Number of shared co-authors 0
Obstetrics and Gynecology Hospital of Fudan University
Career Start Year 1997
Number of shared co-authors 0
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Career Start Year 1996
Number of shared co-authors 0
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute (NCI)
Career Start Year 1994
Number of shared co-authors 0
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 0
Peking University Cancer Hospital
Career Start Year 1989
Number of shared co-authors 0
Korea Advanced Institute of Science and Technology (KAIST)
Career Start Year 1982
Number of shared co-authors 0

Collaborators

The First Affiliated Hospital, Hengyang Medical School, University of South China
Co-authored papers 13
Janssen Pharmaceutical Research & Development
Co-authored papers 2
The University of Manchester, University of Manchester
Co-authored papers 2
Washington University School of Medicine
Co-authored papers 2
Lister Hill National Center for Biomedical Communication
Co-authored papers 2
University of Oxford
Co-authored papers 2
University of Oxford
Co-authored papers 2
Department of Medical Informatics and Clinical Epidemiology
Co-authored papers 2
University of Florida Health
Co-authored papers 2
College of Engineering, University of Arizona
Co-authored papers 2
University of Utah Health
Co-authored papers 2
Erasmus University Medical Center
Co-authored papers 2
University of Oxford
Co-authored papers 2
Hospital del Mar-IMIM, Universitat Pompeu Fabra, Instituto de Salud Carlos III
Co-authored papers 2
O'Brien Institute for Public Health, University of Calgary
Co-authored papers 2
Stanford University
Co-authored papers 2
Columbia University Irving Medical Center
Co-authored papers 2
Ajou University Graduate School of Medicine
Co-authored papers 2
Universidad del Norte
Co-authored papers 2
Columbia University Irving Medical Center
Co-authored papers 2
College of Animal Science and Technology, Northeast Agricultural University
Co-authored papers 2
University of Gothenburg
Co-authored papers 2
University of Utah
Co-authored papers 2
Northeastern University
Co-authored papers 2
Stanford University
Co-authored papers 2
University of Colorado Anschutz Medical Campus
Co-authored papers 2
OHDSI Center at The Roux Institute, Northeastern University
Co-authored papers 2
American College of Medical Informatics, Department of Veteran Affairs, Harvard University T H Chan School of Public Health, Massachusetts Institute of Technology, The American Society for Clinical Investigation, University of Kentucky, Vanderbilt University Medical Center, Vanderbilt University Medical School
Co-authored papers 2
Botnar Research Centre, University of Oxford
Co-authored papers 2
DHC Technologies Co. Ltd.
Co-authored papers 2